Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Altern Ther Health Med ; 28(1): 100-106, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34197339

ABSTRACT

CONTEXT AND OBJECTIVE: Periodontitis and type 2 diabetes (T2D) are chronic diseases generally treated with conventional therapies alone. The aim of this study was to compare the effects of homeopathy as an adjunct to conventional periodontal therapy in individuals with periodontitis and T2D. DESIGN: 85 individuals, age between 35 and 70 years, of both genders, participated in this randomized study; 70 patients were from the Institute of Endocrinology and Diabetes of Rio de Janeiro, Brazil. They were divided into 2 groups: G1, individuals with periodontitis without systemic conditions; and G-2, individuals with periodontitis and T2D. Both groups received homeopathic treatment and were evaluated in clinical and laboratory examinations. The medication used was chosen based on the similarity principle: Berberis 6CH, Mercurius Solubilis/Belladona /Hepar Sulfur and a Pyrogenium 200CH biotherapic. Medications were prescribed in diluted low ultra-diluted concentration doses for all signs and symptoms, while biotherapics were used for chronic stimulation. SETTING: The study was performed in Brazil by university research professors of homeopathy and periodontics. RESULTS: Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total-C), triglycerides, glucose, glycated hemoglobin (A1cHb), uric acid and C-reactive protein (CRP). Statistical and descriptive analyses were performed. For most parameters, G1 performed better than G2 (P < .05). CONCLUSION: Homeopathy as an adjunct to periodontal treatment improves local and systemic clinics and can provide better health conditions for patients with or without T2D.


Subject(s)
Chronic Periodontitis , Diabetes Mellitus, Type 2 , Homeopathy , Adult , Aged , Brazil , Chronic Periodontitis/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Female , Humans , Male , Mercury Compounds , Middle Aged
2.
Complement Ther Clin Pract ; 45: 101482, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34530182

ABSTRACT

INTRODUCTION: According to the World Health Organization, the coronavirus disease 2019 (COVID-19) has 48.896.564 reported cases and 1.236.995 deaths worldwide on November 5, 2020. Despite great efforts, there is no treatment of COVID-19 up to nowadays. Therefore, it is essential to search for therapeutic alternatives to COVID-19, such as Integrative Medicine, especially Homeopathy, which was used with excellent results in the great epidemics. AIM: This study aims to describe the coronavirus Pandemic from the perspective of Classical Systemic Homeopathy and to identify the homeopathic medicine (medicines genius) that has its sphere of action in most of the symptoms involved in this pandemic. METHODS: Articles published in indexed journals and websites of medical institutions, books of homeopathic materia medica, scientific journals, and government publications were reviewed. RESULTS: A total of 39 references were selected and enclosed 20 articles indexed on COVID-19, 08 references of systemic conditions, 11 articles indexed of homeopathy, 06 classic homeopathy books. After the study, the homeopathic medicine Cinchona officinalis (China officinalis) was proposed, according to pathogenesis (experimental pathophysiological study in humans) described in the materia medica books consulted, for the relief of symptoms. Its sphere of action in most of the symptoms involved in this pandemic. Moreover, acute homeopathic medicines were determined to act in the relief of symptoms of the various phases of the manifestations of the disease. CONCLUSION: Data contributes to use in homeopathic interventions during the COVID-19 epidemic as a health promotion and treatment strategy that can be used as an adjunct to all sanitary and therapeutic measures recommended by health authorities.


Subject(s)
COVID-19 , Homeopathy , Materia Medica , Humans , Materia Medica/therapeutic use , Pandemics , SARS-CoV-2
4.
Rio de janeiro; s.n; 2015. 60 p. ilus.
Thesis in Portuguese | LILACS, BBO - dentistry (Brazil) | ID: biblio-1009980

ABSTRACT

Introdução e objetivo: a periodontite crônica (PC) é uma doença inflamatória crônica resultante do rompimento da homeostase entre microbiota subgengival e as defesas do hospedeiro. Como a homeopatia (H) visa restabelecer o equilíbrio da energia vital do paciente permitindo o movimento de cura do organismo. O objetivo do presente estudo foi avaliar os efeitos longitudinais (um ano) da terapia homeopática como coadjuvante no tratamento da periodontite crônica generalizada (PC) em pacientes diabéticos tipo II, sobre os parâmetros clínicos e laboratoriais, e seu impacto na qualidade de vida do paciente. Materiais e métodos: Oitenta pacientes com PC e DM II, de ambos os sexos e com idades entre 32 e 70 anos de idade, participaram desse ensaio clínico randomizado, duplo-cego, placebo-controlado. Os pacientes foram divididos em dois grupos: grupo controle (GC) e o Grupo teste (GT). Ambos os grupos receberam a Terapia periodontal básica (TPB). G-T recebeu adicionalmente a Terapia homeopática (TH): Berberis, Mercurius solubilis/ Belladona/ Hepar sulphur e Pyrogenium, enquanto GC recebeu placebo. As avaliações foram feitas no baseline e após 30 dias, 6 e 12 meses de tratamento. As respostas locais e sistêmicas foram avaliadas por parâmetros clínicos e laboratoriais respectivamente. Também, foi utilizado um questionário de qualidade de vida, Oral Health Impact Profile-14 (OHIP-14). Os dados foram analisados pelos testes paramétricos e não paramétricos. O nível de significância foi de 5%. Resultados: A avaliação intragrupos mostrou melhoras significativas em ambos os grupos, ao longo do estudo, para os parâmetros clínicos periodontais estudados. Na análise laboratorial, G-T mostrou níveis estatisticamente menores de LDL, Colesterol Total, Glicemia, Hemoglobina glicada e ácido úrico após 1ano de acompanhamento. Em relação ao impacto na qualidade de vida, G-T apresentou valores significativamente menores nos domínios limitação funcional, aos seis meses e dor física, aos seis meses. Conclusão: ambos os grupos apresentaram melhoras clínicas periodontais significativas durante o acompanhamento de um ano, No entanto, os resultados sugerem que os medicamentos homeopáticos, como coadjuvante para TPB, podem proporcionar melhoras em parâmetros laboratoriais e qualidade de vida para o tratamento convencional da PC.


Introduction and objective: the chronic periodontitis (CP) is a chronic inflammatory disease that results from the disruption of homeostasis between Subgingival microbiota and host defenses. As Homeopathy (H) aims to restore the balance of the vital energy of the patient allowing the healing movement of the body, the aim of this study was to evaluate the effects of H as a supporting role for basic periodontal therapy (BTP) in individuals with Diabetes mellitus type 2 (DMII).Materials and methods: After the calculation of sample size, 80 individuals with CP and DM II, of both sexes and aged between 32 and 70 years of age, participated in this randomized, double-blind, placebo-controlled. The patients were divided into two groups: control group (GC) and the test group (GT) both groups received the TPB. G-T received Additionally the homeopathic Therapy (TH): Berberis, Mercurius solubilis/Belladonna/Hepar sulphur and Pyrogenium, while GC received placebo. The evaluations were made at baseline and after 30 days, six and 12 months of treatment. The local and systemic responses were evaluated by clinical and laboratory parameters respectively. Also, it was used a questionnaire of quality of life, Oral Health Impact Profile-14 (OHIP-14). Data were analyzed by parametric and nonparametric tests. The significance level was 5%. Results: Intra-group evaluation showed significant improvement in both groups, throughout the study, for most of the parameters studied. G-T and G-C, in three evaluation periods (1, 6 and 12 months), most biofilm (BTI) and lower values of PBS were verified in G-C above the G-T, although similar levels of bleeding have been observed in the same periods; It was observed a value significantly lower NIC in G-T only to 30 days; in laboratory testing, G-T showed statistically lower levels of various parameters, namely: LDL, Total cholesterol and Glucose, glycated Hemoglobin and uric acid after 12 months. In relation to the impact on quality of life, G-T presented significantly lower values in functional domains and physical pain, to six months after BPT Conclusion: both groups showed significant improvement during the follow-up of one year However, the results of the present study suggest that homeopathy as supplement of BTP may improve some laboratory parameters and the quality of life of PC.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Pharmacodynamics of Homeopathic Remedy , Chronic Periodontitis/therapy , Conservative Treatment , Randomized Controlled Trial , Sickness Impact Profile
SELECTION OF CITATIONS
SEARCH DETAIL